Parrish, C., Scott, G. B., Migneco, G., Scott, K. J., Steele, L. P., Ilett, E., . . . Errington-Mais, F. (2015). Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia. Leukemia.
Chicago-tyylinen lähdeviittausParrish, C., et al. "Oncolytic Reovirus Enhances Rituximab-mediated Antibody-dependent Cellular Cytotoxicity against Chronic Lymphocytic Leukaemia." Leukemia 2015.
MLA-viiteParrish, C., et al. "Oncolytic Reovirus Enhances Rituximab-mediated Antibody-dependent Cellular Cytotoxicity against Chronic Lymphocytic Leukaemia." Leukemia 2015.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.